Interim results of phase II study BRF113928 of dabrafenib in BRAF V600E mutation-positive non-small cell lung cancer (NSCLC) patients Meeting Abstract
| Authors: | Planchard, D.; Mazieres, J.; Riely, G. J.; Rudin, C. M.; Barlesi, F.; Quoix, E. A.; Souquet, P. J.; Socinski, M. A.; Switzky, J.; Ma, B.; Goodman, V. L.; Carson, S. W.; Curtis, C. M.; Streit, M. R. W.; Johnson, B. E. |
| Abstract Title: | Interim results of phase II study BRF113928 of dabrafenib in BRAF V600E mutation-positive non-small cell lung cancer (NSCLC) patients |
| Meeting Title: | 49th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 31 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2013 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2013-05-20 |
| Language: | English |
| ACCESSION: | WOS:000335419602491 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2013.31.15_suppl.8009 |
| Notes: | Meeting Abstract: 8009 -- Source: Wos |
